Physicians' Understanding of Consent Requirements for Phase I Clinical Trials in Cognitively Impaired or Highly Vulnerable Patients

Author： Farber N.  

Publisher： Taylor & Francis Ltd

ISSN： 0898-9621

Source： Accountability in Research: Policies and Quality Assurance, Vol.11, Iss.1, 2004-01, pp. : 63-78

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Comprehensibility of Informed Consent Documents in HIV-related Clinical Trials

By  

The International Journal of the Humanities: Annual Review, Vol. 8, Iss. 9, 2010-01 ,pp. : 183-196

Common Ground Publishing

Access to resources Recommend Favorite

Physicians’ Religious Topic Avoidance during Clinical Interactions

By Villagran Melinda M.   MacArthur Brenda L.   Lee Lauren E.   Ledford Christy J. W.   Canzona Mollie R.  

Behavioral Sciences, Vol. 7, Iss. 2, 2017-05 ,pp. : 30-30

MDPI

Access to resources Recommend Favorite

Public Involvement in the Design and Conduct of Clinical Trials

By  

The International Journal of Interdisciplinary Social Sciences: Annual Review, Vol. 5, Iss. 11, 2011-01 ,pp. : 91-112

Common Ground Publishing

Access to resources Recommend Favorite

Gene technology in humans: can the responsibilities be borne by scientists, physicians, and patients?

By Cramer Friedrich  

Interdisciplinary Science Reviews, Vol. 26, Iss. 3, 2001-09 ,pp. : 162-166

Maney Publishing

Access to resources Recommend Favorite

Factory ''homers'': Understanding a highly elusive, marginal, and illegal practice

By Anteby M.  

Sociologie du Travail, Vol. 45, Iss. 4, 2003-10 ,pp. : 453-471

Elsevier

Access to resources Recommend Favorite